MV-Optimizer is a clinical prognosis software developed to assist physicians in the management of mechanical ventilation (MV), an artificial technique that partially or fully replaces the function of the respiratory muscles of a person who cannot breathe on his own. MV influences natural respiration by improving oxygenation and CO2 elimination while the causes that lead to the need for MV are resolved. MV-Optimizer was part of one of the 13 innovative science-based projects of the UPC of the ‘Knowledge Industry’ program and has been selected by IESE in the BTTG technology transfer accelerator program. Currently, it participates in the Barcelona Activa pre-acceleration program.